open access

Vol 3, No 1 (2010)
SPRAWOZDANIA, KOMUNIKATY
Published online: 2010-03-19
Get Citation

Sprawozdanie z XIX Regionalnego Zjazdu Międzynarodowego Towarzystwa Przetaczania Krwi (ISBT) oraz z obrad Grupy Roboczej ds. Zakażeń Przenoszonych przez Krew ISBT, Kair, Egipt, 21-25 marca 2009 roku

Ewa Brojer, Magdalena Łętowska
Journal of Transfusion Medicine 2010;3(1):27-34.

open access

Vol 3, No 1 (2010)
SPRAWOZDANIA, KOMUNIKATY
Published online: 2010-03-19

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Sprawozdanie z XIX Regionalnego Zjazdu Międzynarodowego Towarzystwa Przetaczania Krwi (ISBT) oraz z obrad Grupy Roboczej ds. Zakażeń Przenoszonych przez Krew ISBT, Kair, Egipt, 21-25 marca 2009 roku

Journal

Journal of Transfusion Medicine

Issue

Vol 3, No 1 (2010)

Pages

27-34

Published online

2010-03-19

Bibliographic record

Journal of Transfusion Medicine 2010;3(1):27-34.

Authors

Ewa Brojer
Magdalena Łętowska

References (45)
  1. Allain JP. infection in the Mediterranean basin and Europe. Vox Sang. 2009; 96(supl. 1): 17.
  2. Ekiaby Magdy E.l., Allain J-P, Lelie N. Hepatitis B virus DNA and surface antigen particle concentration of ultra-sensitive nucleic acid screening tests in HBsAg carriers. Vox Sang. 2009; 96(supl. 1): 17.
  3. Grabarczyk P, Garniri P, Brojer E, et al. Polimorphism of Hepatitis B wirus from first time blond donors with HBsAg in Poland. Vox Sang. 2009; 96(supl. 1): 18.
  4. Meldal B, Mojaar N, Barnes I, et al. A new Hepatitis B virus subtype D6 in Tunisian blood donors. Vox Sang. 2009; 96(supl. 1): 18.
  5. Busch MP, Kleinman SH. Hepatitis C infection: recent insights relevant to transfusion safety. Vox Sang. 2009; 96(supl. 1): 22.
  6. Busch MP, Kleinman SH. Hepatitis C infection: recent insights relevant to transfusion safety. ISBT Science Series. 2009; 4(1): 72–79.
  7. Rios M. Climate change and vector-borne viral diseases potentially transmitted by transfusion. ISBT Science Series. 2009; 4(1): 87–94.
  8. Leiby D, Nguyen M, Goff T, et al. Shifting the focus of malria deferrals:time for a new paradigm. Vox Sang. 2009; 96(supl. 1): 38.
  9. Assal A, Auger F, Corbi C, et al. Trypanasoma cruzi detection and quantification by real-time PCR. Vox Sang. 2009; 96(supl. 1): 39.
  10. Burger R. Emerging pathogens and possible threats to blood services. ISBT Science Series; Vox Sang. 2009; 4: 121.
  11. Burger R. Emerging pathogens and possible threats to blood services. Vox Sang. 2009; 96(supl. 1): 51.
  12. Sambri V, Cavrini F, et al. D’Angelo E. The outbreak of West Nile virus infection in Northern Italy: an additional new risk for the safety of blood and organ donation. Vox Sang. 2009; 96(supl. 1): 52.
  13. Kleinman S, Drimmelen AA. J., Lelie P.N., Busch M.P. Minipool Nat HIV-1 breakthrough transmission cases and probability of interdiction current small pool or individual-donation Nat screening systems. Vox Sang. 2009; 96(supl. 1): 53.
  14. Piron M, Romero A, Cosamitiana M, et al. HTLV-I/II prevalance in at-risk blood donors from Central and South America in A non-endemic area (Catalonia, Spain). Vox Sang. 2009; 96(supl. 1): 54.
  15. Schmidt M, Mayr-Wohlfart U, Kai M, et al. Infectivity of B19 positive blood products. Vox Sang. 2009; 96(supl. 1): 54.
  16. Kopacz A, Grabarczyk P, Sulkowska E, et al. The results of look back and trace back procedures for HBV DNA positive/ /HBsAg negative donors identified in Poland. Vox Sang. 2009; 96(supl. 1): 15.
  17. Belkacemi M. Prevalence of HIV in blood donors in the department of Sidi Bel Abbes in the democtratic and popular Algerian Republik. Vox Sang. 2009; 96(supl. 1): 104.
  18. Durro V, Korrqi A, Qyra M, et al. Epidemiology of transfusion-transmitted infections in multi transfused patients in Albania. Vox Sang. 2009; 96(supl. 1): 106.
  19. Eita N. Prevalence of HCV and HBV infections among blood donors in Dakahilia, Egypt. Vox Sang. 2009; 96(supl. 1): 106.
  20. Gamlath PM. G.R. The Incidence and trends of HBsAg, anti HCV, anti HIV I et II, antibodies to Treponemia Palladium and slide test for malaria parasite in Sri Lankan blood donations. Vox Sang. 2009; 96(supl. 1): 107.
  21. Jovanovic P. Levicnik Stecinar S. Prevalence of Anti-HTLVI/II in Slovenian blood donors and the impact on blood screening. Vox Sang. 2009; 96(supl. 1): 109.
  22. Kocovska E, Timova T, Momiroska T, et al. The prevalence of anti-HCV positive in blood donors in Clinic HospitalTetovo. Vox Sang. 2009; 96(supl. 1): 91.
  23. Ghiazza P, Demarin G, Demarchi G, et al. Analytical and technical performances evaluation on Procleix Tigris System for NAT screening in Italy. Vox Sang. 2009; 96(supl. 1): 90.
  24. Glauser A, Hardegger K, Gottschalk J, et al. Four parameter NAT screening by taqscreen MPX with Cobas S201 in Switzerland: validation, implementation and first experiences. Vox Sang. 2009; 96(supl. 1): 107.
  25. Queiros L, Teixeria A, Coelho G. Performance evaluation of a new fully automated HTLV-I/HTLV-II assay in Portuguese blood donors. Vox Sang. 2009; 96(supl. 1): 111.
  26. Queiros L, Teixeria A, Coelho G, et al. Specificity of architect anti-HBC II assay in comparison to prism HBCORE Assay in Portuguese blood donors. Vox Sang. 2009; 96(supl. 1): 86.
  27. Vucetic D, Trkuljic M, Balint B, et al. Combined human immunodeficiency virus antigen-antibody assay investigation among blood donors in Serbia. Vox Sang. 2009; 96(supl. 1): 113.
  28. Ziermann R, Ohhashi Y, Pai A, et al. Comparative clinical evaluation of the cobas taqscreen MPX Test with the Cobas Ampliscreen HIV-1 V1.5, HCV V2.O, and HBV Tests using high risk population and seropositive specimens. Vox Sang. 2009; 96(supl. 1): 95.
  29. Mihaljevic I. Evaluation of the architect HCV antigen assay for use in organ and tissue donors. Vox Sang. 2009; 96(supl. 1): 24.
  30. Mirshafiee H, Milani S, Sharifi Z, et al. Genotype analysis of HBV and HDV in Teheran, Iran. Vox Sang. 2009; 96(supl. 1): 83.
  31. Grabarczyk P, Kalińska A, Sulkowska E, et al. Polymorphism and extremely high viraemia observed in parvovirus B19 diagnostic samples-potential difficulties that could be faced during B19 screening in blood donors. Vox Sang. 2009; 96(supl. 1): 108.
  32. Naroozi M, Shafiri Z, Gharehbaghian A. Genotyping and phylogenetic analysis of the polymerase gene of HBV in volunteer blood donors in Iran. Vox Sang. 2009; 96(supl. 1): 84.
  33. Neves I, Boavida M, Peres C, et al. HBV Genotypes in blood donors of Lisbon Regional Blood Centre. Vox Sang. 2009; 96(supl. 1): 84.
  34. Kolundzija SK. Results of testing of confirmed positive voluntary blood donors to Hepatitis C markers — two years experience. Vox Sang. 2009; 96(supl. 1): 91.
  35. Kourenti A, Faukitsa V, Stamoulis K, et al. The contribution of PCR to determine the anti-HCV positive blood donors and RIBA negative or indeterminate. Vox Sang. 2009; 96(supl. 1): 91.
  36. Di Tullio Budassi L., Di Paolo O. HTLV I/II Western Blot Assay as a complementary test for donor folow up and counselling. Vox Sang. 2009; 96(supl. 1): 104.
  37. Alexopoulos A, Tseliou P. Four years experience with ID NAT testing in blood donations in Southwestern Greece. Vox Sang. 2009; 96(supl. 1): 78.
  38. Anwar F, Abdeinaal M, Khalid H, et al. Living with NAT: our experience at King Khalid National Guard Hospital, Jeddha, Saudi Arabia. Updates on Hepatitis C (HCV). Vox Sang. 2009; 96(supl. 1): 89.
  39. Neves L, Boavida N, Luig F, et al. Five years experience of NAT individual donation in Lisbon regional blood centre donors. Vox Sang. 2009; 96(supl. 1): 111.
  40. Nograsek P, Javonovic P. Levicnik Stezinar S. Experience in NAT screening: comparison of PCR and TMA based systems. Vox Sang. 2009; 96(supl. 1): 94.
  41. Keil S, Gilmour D, Miklauz M, et al. Photochemical inactivation of human Hepatitis B virus using the mirasol pathogen reduction technology (PRT) system as measured by PCR. Vox Sang. 2009; 96(supl. 1): 82.
  42. Yokomizo T, Nirasawa H, Kai T, et al. A combination filter for prion and leucocyte reduction, its prion reduction performance in spiking test assessed by bioassay. Vox Sang. 2009; 96(supl. 1): 114.
  43. Gonzalez Fraile M.I., del Bianko A.I.J., Golvano Guerrero E. Occult Hepatitis B infection in blood donors: a real problem. Vox Sang. 2009; 96(supl. 1): 19.
  44. Lam TP. DNA detection on HBsAg non-reactive/anti HBC reactive donation samples. Vox Sang. 2009; 96(supl. 1): 83.
  45. Politis CP, Vrettou H, Fragatou S, et al. Prevalence of occult Hepatitis B (OBI) in thalassaemic patients in Greece: a multicentre retrospective study. Vox Sang. 2009; 96(supl. 1): 85.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Journal of Transfusion Medicine dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest Via Medica sp. z o.o. sp. komandytowa, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl